期刊文献+

先天性心脏病相关性肺动脉高压患者血miR-18a、miR-27b、miR-130a、miR-204水平研究 被引量:4

The changes of plasma miR-18a, miR-27b, miR-130a, miR-204 in patients with pulmonary arterial hypertension due to congenital heart disease
下载PDF
导出
摘要 目的 探索先天性心性脏病相关性肺动脉高压(PAH)患者血清中miR-18a、miR-27b、miR-130a和miR-204的表达水平,以及与PAH的相关性.方法 收集昆明医科大学附属延安医院心血管内科2012年4~12月被确诊为先天性心脏病的患者78例,其中肺动脉压正常组37例,合并轻、中度肺动脉高压组25例,重度肺动脉高压组16例;另设正常对照组20例.应用实时荧光定量PCR (Taqman探针法)检测miR-18a、miR-27b、miR-130a、miR-204在血液中的表达水平,分析先天性心脏病相关性肺动脉高压与miR-NA表达水平之间的关系.结果 先天性心脏病相关肺动脉高压患者血miR-18a、miR-27b、miR-130a表达水平显著上调,miR-204表达水平显著下调.随着肺动脉压力的不断增高,血miR-18a、miR-27b、miR-130a表达量明显升高,miR-204表达量显著下调.直线相关分析显示,先天性心脏病继发性肺动脉高压患者血miR-18a、miR-27b、miR-130a表达水平与肺动脉压力存在高度正相关关系(r=0.927,r=0.927,r=0.933,P<0.01),miR-204表达水平与肺动脉压力存在高度负相关关系(r=-0.773,P<0.01).结论 血miR-18a、miR-27b、miR-130a、miR-204水平可作为判断先天性心脏病合并肺动脉高压较好的临床血清学指标,预判价值较高. Objective To detect the serum level of miR-18a,miR-27b,miR-130a and miR-204 in patients with pulmonary arterial hypertension due to congenital heart disease,and investigated the correlation of those with pulmonary hypertension.Methods 78 patients with congenital heart disease in the department of cardiology of Yan'an Affiliated Hospital of Kunming Medical University between April and Dcemeber 2012 and 20 normal control patients were collected.The patients with congenital heart disease were divided into 37 cases of nonpulmonary arterial hypertension group,25 cases of mild to moderate pulmonary arterial hypertension,and 16 cases of severe pulmonary arterial hypertension.The serum level of miR-18a,miR-27b,miR-130a and miR-204 were detected by using real-time fluoresecnt quantitative PCR (Taqman probe),and the relationship between serum miRNAs and pulmonary arterial pressure were analyzed and investigated the correlation between and PH.Results The expression level of miR-18a,miR-27b and miR-130a in CHD with PAH patients were significantly higher than normal group,the expression level of miR-204 was significantly lower than normal group.The pulmonary arterial pressure was significant positively correlated with miR-18a,miR-27b,miR-130a (r=0.927,r=0.927,r=0.933,P〈0.01).Conclusion The expression levels of miR-18a,miR-27b and miR-130a and miR-204 can be used as the good clinical serological indexes for diagnosis of patients with pulmonary arterial hypertension due to congenital heart disease.
出处 《中国心血管病研究》 CAS 2014年第9期785-788,共4页 Chinese Journal of Cardiovascular Research
基金 昆明市医药卫生科技项目 云南省博士研究生学术新人奖
关键词 先天性心脏病 肺动脉高压 微小RNA Pulmonary arterial hypertension Congenital heart disease MicroRNA
  • 相关文献

参考文献8

  • 1Duka I,Gavras I.Vasoactive potential of the b(1) bradykinin receptor in normotension and hypertension.Circ Res,2001,16:275-281.
  • 2Yamazato Y,Hong KH.Prevention of pulmonary hypertension by Angiotensin-converting enzyme 2 gene transfer.Hypertension,2009,54:365-371.
  • 3Ruzinova MB,Benezra R.Id proteins in development,cell cycle and cancer.Trends Cell Biol,2003,13:410-418.
  • 4孙妍,薛军,吴迪,马宁.MiRNAs与心肌肥厚的相关性研究[J].中国心血管病研究,2013,11(4):300-302. 被引量:2
  • 5龚永飞,戴海龙,尹小龙.MiRNA在冠心病患者单核-巨噬细胞中的表达与功能研究[J].中国心血管病研究,2013,11(9):725-729. 被引量:4
  • 6Brock M,Trenkmann M,Gay RE,et al.Interleukin-6 modulates the expression of the bone morphogenic protein receptor type Ⅱ through a novel STAT3-microRNA cluster 17/92 pathway.Circ Res,2009,104:1184-1191.
  • 7Courboulin A,Paulin R,Giguère NJ,et al.Role for miR-204 in human pulmonary arterial hypertension.J Exp Med,2011,208:535-548.
  • 8陈伟丹,花中东,杨克明,孟强,张浩,张瑛,潘湘斌,王德,李岩,李守军.microRNA在先天性心脏病继发性肺动脉高压肺组织内变化的实验研究[J].中国细胞生物学学报,2010,32(4):601-605. 被引量:7

二级参考文献62

  • 1张璞,肖传实.心血管疾病基因治疗[J].中国心血管病研究,2006,4(5):394-396. 被引量:5
  • 2柯俊,张存泰,马业新.CaMKⅡ与心肌肥厚[J].中国心血管病研究,2006,4(12):936-938. 被引量:2
  • 3Du T, Zamore PD. microPrimer: the biogenesis and function of microRNA. Development 2005;132(21): 4645-52.
  • 4Alvarez-Garcia I, Miska EA. MicroRNA functions in animal development and human disease. Development 2005; 132(21): 4653-62.
  • 5Lovis P, Gattesco S, Regazzi R. Regulation of the expression of components of the exocytotic machinery of insulin-secreting cells by microRNAs. Biol Chem 2008; 389(3): 305-12.
  • 6Chen Y, Gorski DH. Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5. Blood 2008; 111(3): 1217-26.
  • 7Kuehbacher A, Urbich C, Zeiher AM, Dimmeler S. Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circ Res 2007; 101(1): 59-68.
  • 8Brock M, Trenkmann M, Gay RE, Michel BA, Gay S, Fischler M, et al. Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway. Circ Res 2009; 104(10): 1184-91.
  • 9Rabinovitch M. Molecular pathogenesis of pulmonary arterial hypertension. J Clin Invest 2008; 118(7): 2372-9.
  • 10Lee DY, Deng Z, Wang CH, Yang BB. MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression. Proc Natl Acad Sci USA 2007; 104(51): 20350-5.

共引文献10

同被引文献41

  • 1Inglessis I, Landzberg MJ.Interventional catheterization in adult congenital heart disease[J].Circulation, 2007, 115 (12):1622-1633.
  • 2Diller GP, Gatzoulis MA.Pulmonary vascular disease in adults with congenital heart disease[J].Circulation, 2007, 115 (8) :1039-1050.
  • 3Munagala VK, Burnett JC Jr, Redfield MM.The natriuretic peptides in cardiovascular medicine[J].Curr Probl Cardiol, 2004,29(12) :707-769.
  • 4Bernus A, Wagner BD, Accurso F, et al.Brain natriuretic peptide levels in managing pediatric patients with pulmonary arterial hypertension[J].Chest, 2009,135 (3) :745-751.
  • 5Reynolds EW, Ellington JG, Vranicar M, et al.Brain-type natriuretic peptide in the diagnosis and management of persistent pulmonary hypertension of the newborn[J].Pediatrics, 2004,114(5) :1297-1304.
  • 6Currie PJ, Seward JB, Chan KL, et al.Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler-catheterization study in 127 patients[J].J Am Coll Cardiol, 1985,6(4) :750-756.
  • 7Galiè N, Hoeper MM, Humbert M, et al.Guidelines for the diagnosis and treatment of pulmonary hypertension : the Task Force for the Diagnosis andTreatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the EuropeanRespiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)[J].Eur Heart J, 2009,30 (20) :2493-2537.
  • 8Cantinotti M, Vittorini S, Storti S, et al.Diagnostic accuracy and clinical relevance of brain natriuretic peptide assay in pediatric patients with congenital heart diseases[J].J Cardiovasc Med (Hagerstown) , 2009,10 (9) :706-713.
  • 9Nagaya N, Nishikimi T, Okano Y, et al.Plasma brain natriuretic peptide levels increase in proportion to the extend of fight ventricular dysfunction in pulmonary hypertension[J].J Am Coll Cardiol, 1998,31 (1) :202-208.
  • 10Niizck T, Takeishi Y, Arimoto T, et al.Combination of heart-type facty acid bindy protein and brain natriuretic peptide can reliably risk stratify patients hospitalized for chronic heart failure[J].Circ J, 2005,69(8) :922-927.

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部